<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35152451</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>10</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-2990</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>48</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Neuropathology and applied neurobiology</Title>
          <ISOAbbreviation>Neuropathol Appl Neurobiol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The severity of behavioural symptoms in FTD is linked to the loss of GABRQ-expressing VENs and pyramidal neurons.</ArticleTitle>
        <Pagination>
          <StartPage>e12798</StartPage>
          <MedlinePgn>e12798</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/nan.12798</ELocationID>
        <Abstract>
          <AbstractText Label="AIMS" NlmCategory="OBJECTIVE">The loss of von Economo neurons (VENs) and GABA receptor subunit theta (GABRQ) containing neurons is linked to early changes in social-emotional cognition and is seen in frontotemporal dementia (FTD) due to C9orf72 repeat expansion. We investigate the vulnerability of VENs and GABRQ-expressing neurons in sporadic and genetic forms of FTD with different underlying molecular pathology and their association with the presence and severity of behavioural symptoms.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We quantified VENs and GABRQ-immunopositive neurons in the anterior cingulate cortex (ACC) in FTD with underlying TDP43 (FTLD-TDP) (n = 34), tau (FTLD-tau) (n = 24) or FUS (FTLD-FUS) (n = 8) pathology, neurologically healthy controls (n = 12) and Alzheimer's disease (AD) (n = 7). Second, we quantified VENs and the GABRQ-expressing population in relation to presence of behavioural symptoms in the first years of disease onset.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The number of VENs and GABRQ-expressing neurons and the ratio of VENs and GABRQ-expressing neurons over total Layer 5 neuronal population decreased in FTLD-TDP and FTLD-FUS, but not in FTLD-tau, compared to control and AD. The severity of early behavioural symptoms in all donors correlated with a lower VEN and GABRQ neuronal count.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We show that in FTD, a loss of VENs together with GABRQ-expressing pyramidal neurons is associated with TDP43 and FUS pathology. No significant loss was found in donors with FTLD-tau pathology; however, this could be due to the specific MAPT mutation studied and small sporadic FTLD-tau sample size. Overall, we show the GABRQ-expressing population correlates with behavioural changes and suggest they are key in modulating behaviour in FTD.</AbstractText>
          <CopyrightInformation>© 2022 The Authors. Neuropathology and Applied Neurobiology published by John Wiley &amp; Sons Ltd on behalf of British Neuropathological Society.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Gami-Patel</LastName>
            <ForeName>Priya</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">0000-0002-5263-8706</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Amsterdam Neuroscience, Amsterdam University Medical Centre, Amsterdam, Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Scarioni</LastName>
            <ForeName>Marta</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0002-2420-6447</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Amsterdam Neuroscience, Amsterdam University Medical Centre, Amsterdam, Netherlands.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Alzheimer Centre, Amsterdam Neuroscience, Amsterdam University Medical Centre, Amsterdam, Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bouwman</LastName>
            <ForeName>Femke H</ForeName>
            <Initials>FH</Initials>
            <Identifier Source="ORCID">0000-0002-0527-2270</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Alzheimer Centre, Amsterdam Neuroscience, Amsterdam University Medical Centre, Amsterdam, Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Boon</LastName>
            <ForeName>Baayla D C</ForeName>
            <Initials>BDC</Initials>
            <Identifier Source="ORCID">0000-0002-4922-3286</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Amsterdam Neuroscience, Amsterdam University Medical Centre, Amsterdam, Netherlands.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Alzheimer Centre, Amsterdam Neuroscience, Amsterdam University Medical Centre, Amsterdam, Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>van Swieten</LastName>
            <ForeName>John C</ForeName>
            <Initials>JC</Initials>
            <Identifier Source="ORCID">0000-0001-6278-6844</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Alzheimer Centre, Erasmus MC, Rotterdam, Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brain Bank</LastName>
            <ForeName>Netherlands</ForeName>
            <Initials>N</Initials>
            <Identifier Source="ORCID">0000-0003-3713-8364</Identifier>
            <AffiliationInfo>
              <Affiliation>Netherlands Brain Bank, Netherlands Institute for Neuroscience, Amsterdam, Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rozemuller</LastName>
            <ForeName>Annemieke J M</ForeName>
            <Initials>AJM</Initials>
            <Identifier Source="ORCID">0000-0003-2528-4428</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Amsterdam Neuroscience, Amsterdam University Medical Centre, Amsterdam, Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Smit</LastName>
            <ForeName>August B</ForeName>
            <Initials>AB</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Molecular and Cellular Neurobiology, Centre for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam, Amsterdam, Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pijnenburg</LastName>
            <ForeName>Yolande A L</ForeName>
            <Initials>YAL</Initials>
            <Identifier Source="ORCID">0000-0003-2464-1905</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Alzheimer Centre, Amsterdam Neuroscience, Amsterdam University Medical Centre, Amsterdam, Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hoozemans</LastName>
            <ForeName>Jeroen J M</ForeName>
            <Initials>JJM</Initials>
            <Identifier Source="ORCID">0000-0002-2888-8967</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Amsterdam Neuroscience, Amsterdam University Medical Centre, Amsterdam, Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dijkstra</LastName>
            <ForeName>Anke A</ForeName>
            <Initials>AA</Initials>
            <Identifier Source="ORCID">0000-0003-2160-587X</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Amsterdam Neuroscience, Amsterdam University Medical Centre, Amsterdam, Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>733050507</GrantID>
            <Acronym>ZONMW_</Acronym>
            <Agency>ZonMw</Agency>
            <Country>Netherlands</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>02</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Neuropathol Appl Neurobiol</MedlineTA>
        <NlmUniqueID>7609829</NlmUniqueID>
        <ISSNLinking>0305-1846</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C561870">GABRQ protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D011963">Receptors, GABA-A</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001526" MajorTopicYN="N">Behavioral Symptoms</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006179" MajorTopicYN="N">Gyrus Cinguli</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017966" MajorTopicYN="N">Pyramidal Cells</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011963" MajorTopicYN="N">Receptors, GABA-A</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">GABRQ</Keyword>
        <Keyword MajorTopicYN="N">frontotemporal dementia (FTD)</Keyword>
        <Keyword MajorTopicYN="N">social-emotional behaviour</Keyword>
        <Keyword MajorTopicYN="N">von Economo neuron (VEN)</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>11</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>13</Day>
          <Hour>20</Hour>
          <Minute>38</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35152451</ArticleId>
        <ArticleId IdType="doi">10.1111/nan.12798</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134(Pt 9):2456-2477. doi:10.1093/brain/awr179</Citation>
        </Reference>
        <Reference>
          <Citation>Lomen-Hoerth C, Anderson T, Miller B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology. 2002;59(7):1077-1079. doi:10.1212/WNL.59.7.1077</Citation>
        </Reference>
        <Reference>
          <Citation>Devenney EM, Ahmed RM, Halliday G, Piguet O, Kiernan MC, Hodges JR. Psychiatric disorders in C9orf72 kindreds: Study of 1,414 family members. Neurology. 2018;91(16):e1498-e1507. doi:10.1212/WNL.0000000000006344</Citation>
        </Reference>
        <Reference>
          <Citation>Mackenzie IR, Neumann M. Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies. J Neurochem. 2016;138(Suppl 1):54-70. doi:10.1111/jnc.13588</Citation>
        </Reference>
        <Reference>
          <Citation>Lee VM, Goedert M, Trojanowski JQ. Neurodegenerative tauopathies. Annu Rev Neurosci. 2001;24(1):1121-1159. doi:10.1146/annurev.neuro.24.1.1121</Citation>
        </Reference>
        <Reference>
          <Citation>Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130-133. doi:10.1126/science.1134108</Citation>
        </Reference>
        <Reference>
          <Citation>Cruts M, Gijselinck I, van der Zee J, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature. 2006;442(7105):920-924. doi:10.1038/nature05017</Citation>
        </Reference>
        <Reference>
          <Citation>Baker M, Mackenzie IR, Pickering-Brown SM, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006;442(7105):916-919. doi:10.1038/nature05016</Citation>
        </Reference>
        <Reference>
          <Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72(2):245-256. doi:10.1016/j.neuron.2011.09.011</Citation>
        </Reference>
        <Reference>
          <Citation>Gami-Patel P, van Dijken I, van Swieten JC, et al. Von Economo neurons are part of a larger neuronal population that are selectively vulnerable in C9orf72 frontotemporal dementia. Neuropathol Appl Neurobiol. 2019;45(7):671-680. doi:10.1111/nan.12558</Citation>
        </Reference>
        <Reference>
          <Citation>Yang Y, Halliday GM, Hodges JR, Tan RH. von Economo neuron density and thalamus volumes in behavioral deficits in frontotemporal dementia cases with and without a C9ORF72 repeat expansion. J Alzheimers Dis. 2017;58(3):701-709. doi:10.3233/JAD-170002</Citation>
        </Reference>
        <Reference>
          <Citation>Seeley WW, Carlin DA, Allman JM, et al. Early frontotemporal dementia targets neurons unique to apes and humans. Ann Neurol. 2006;60(6):660-667. doi:10.1002/ana.21055</Citation>
        </Reference>
        <Reference>
          <Citation>Santillo AF, Englund E. Greater loss of von Economo neurons than loss of layer II and III neurons in behavioral variant frontotemporal dementia. Am J Neurodegener Dis. 2014;3(2):64-71.</Citation>
        </Reference>
        <Reference>
          <Citation>Kim EJ, Sidhu M, Gaus SE, et al. Selective frontoinsular von Economo neuron and fork cell loss in early behavioral variant frontotemporal dementia. Cereb Cortex. 2012;22(2):251-259. doi:10.1093/cercor/bhr004</Citation>
        </Reference>
        <Reference>
          <Citation>Santillo AF, Nilsson C, Englund E. von Economo neurones are selectively targeted in frontotemporal dementia. Neuropathol Appl Neurobiol. 2013;39(5):572-579. doi:10.1111/nan.12021</Citation>
        </Reference>
        <Reference>
          <Citation>Nimchinsky EA, Vogt BA, Morrison JH, Hof PR. Spindle neurons of the human anterior cingulate cortex. J Comp Neurol. 1995;355(1):27-37. doi:10.1002/cne.903550106</Citation>
        </Reference>
        <Reference>
          <Citation>von Economo C. Eine neue art spezialzellen des lobus cinguli und lobus insulae. Zeitschrift für Die Gesamte Neurologie Und Psychiatrie. 1926;100(1):706-712. doi:10.1007/BF02970950</Citation>
        </Reference>
        <Reference>
          <Citation>Hakeem AY, Sherwood CC, Bonar CJ, Butti C, Hof PR, Allman JM. Von Economo neurons in the elephant brain. Anat Rec (Hoboken). 2009;292(2):242-248. doi:10.1002/ar.20829</Citation>
        </Reference>
        <Reference>
          <Citation>Butti C, Sherwood CC, Hakeem AY, Allman JM, Hof PR. Total number and volume of Von Economo neurons in the cerebral cortex of cetaceans. J Comp Neurol. 2009;515(2):243-259. doi:10.1002/cne.22055</Citation>
        </Reference>
        <Reference>
          <Citation>Allman JM, Tetreault NA, Hakeem AY, et al. The von Economo neurons in the frontoinsular and anterior cingulate cortex. Ann N Y Acad Sci. 2011;1225(1):59-71. doi:10.1111/j.1749-6632.2011.06011.x</Citation>
        </Reference>
        <Reference>
          <Citation>Dijkstra AA, Lin LC, Nana AL, Gaus SE, Seeley WW. Von Economo neurons and fork cells: a neurochemical signature linked to monoaminergic function. Cereb Cortex. 2018;28(1):131-144. doi:10.1093/cercor/bhw358</Citation>
        </Reference>
        <Reference>
          <Citation>Nimchinsky EA, Gilissen E, Allman JM, Perl DP, Erwin JM, Hof PR. A neuronal morphologic type unique to humans and great apes. Proc Natl Acad Sci U S a. 1999;96(9):5268-5273. doi:10.1073/pnas.96.9.5268</Citation>
        </Reference>
        <Reference>
          <Citation>Scarioni M, Gami-Patel P, Timar Y, et al. Frontotemporal Dementia: Correlations Between Psychiatric Symptoms and Pathology. Ann Neurol. 2020;87(6):950-961. doi:10.1002/ana.25739</Citation>
        </Reference>
        <Reference>
          <Citation>Lin LC, Nana AL, Hepker M, et al. Preferential tau aggregation in von Economo neurons and fork cells in frontotemporal lobar degeneration with specific MAPT variants. Acta Neuropathol Commun. 2019;7(1):159. doi:10.1186/s40478-019-0809-0</Citation>
        </Reference>
        <Reference>
          <Citation>Nana AL, Sidhu M, Gaus SE, et al. Neurons selectively targeted in frontotemporal dementia reveal early stage TDP-43 pathobiology. Acta Neuropathol. 2018;137(1):27-46. doi:10.1007/s00401-018-1942-8</Citation>
        </Reference>
        <Reference>
          <Citation>Geuens T, Bouhy D, Timmerman V. The hnRNP family: insights into their role in health and disease. Hum Genet. 2016;135(8):851-867. doi:10.1007/s00439-016-1683-5</Citation>
        </Reference>
        <Reference>
          <Citation>Polymenidou M, Lagier-Tourenne C, Hutt KR, et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci. 2011;14(4):459-468. doi:10.1038/nn.2779</Citation>
        </Reference>
        <Reference>
          <Citation>De Conti L, Akinyi MV, Mendoza-Maldonado R, Romano M, Baralle M, Buratti E. TDP-43 affects splicing profiles and isoform production of genes involved in the apoptotic and mitotic cellular pathways. Nucleic Acids Res. 2015;43(18):8990-9005. doi:10.1093/nar/gkv814</Citation>
        </Reference>
        <Reference>
          <Citation>Lagier-Tourenne C, Polymenidou M, Hutt KR, et al. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat Neurosci. 2012;15(11):1488-1497. doi:10.1038/nn.3230</Citation>
        </Reference>
        <Reference>
          <Citation>de Boer EMJ, Orie VK, Williams T, et al. TDP-43 proteinopathies: a new wave of neurodegenerative diseases. J Neurol Neurosurg Psychiatry. 2020;92(1):86-95. doi:10.1136/jnnp-2020-322983</Citation>
        </Reference>
        <Reference>
          <Citation>Ishigaki S, Sobue G. Importance of Functional Loss of FUS in FTLD/ALS. Front Mol Biosci. 2018;5:44 doi:10.3389/fmolb.2018.00044</Citation>
        </Reference>
        <Reference>
          <Citation>Broe M, Hodges JR, Schofield E, Shepherd CE, Kril JJ, Halliday GM. Staging disease severity in pathologically confirmed cases of frontotemporal dementia. Neurology. 2003;60(6):1005-1011. doi:10.1212/01.WNL.0000052685.09194.39</Citation>
        </Reference>
        <Reference>
          <Citation>Klioueva NM, Rademaker MC, Dexter DT, et al. BrainNet Europe's Code of Conduct for brain banking. J Neural Transm (Vienna). 2015;122(7):937-940. doi:10.1007/s00702-014-1353-5</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
